NEW YORK,today announced that Philosys announced today that it has applied for approval from the U.S. Food and Drug Administration (FDA) for its Gmate® blood glucose monitoring system in Q4 2011, and expects approval in third quarter 2012. The new Gmate® SMART is the smallest and most innovative meter in the world. It's Smartphone technology is patent pending, and is the world's only blood glucose meter to work with the headphone connector of the iPhone, iPad, and iPod.
"We are very excited to be close to FDA approval for our blood glucose monitoring technology and are preparing to bring this capability to the United States," said Jennifer Kupar, Operations Manager for Philosys. Gmate® SMART is the world's first "True Smartphone Meter." Given the dramatic rise of diabetes in the US and more tech savvy consumers, there is a growing demand for this medical technology that Philosys can meet."
Diabetic technology in the U.S. has not kept pace with the digital explosion of smartphones, tablets, and other digital devises. The US Centers for Disease Control predicts that as many as 1 in 3 U.S. adults could have diabetes by 2050. This increase could bring the average incidence of diabetes to more than 30 percent of the population.
"More and more U.S. consumers with diabetes are purchasing Smartphones daily," Kupar continued. "Gmate® is the perfect solution for diabetics seeking digital solutions to monitor their disease with the push of a button. We look forward to FDA approval of our revolutionary device this year."
PR Newswire